Walnut Creek, CA, United States of America

Masoud Mokhtarani

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 2.0

ph-index = 9

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Masoud Mokhtarani

Introduction

Masoud Mokhtarani is a notable inventor based in Walnut Creek, California. He has made significant strides in the field of medicine, with a remarkable portfolio of 18 patents to his name. His work primarily focuses on addressing critical health disorders in neonates and infants.

Latest Patents

Among his latest patents, Mokhtarani has developed innovative treatments for urea cycle disorders in young patients. One of his groundbreaking inventions involves nitrogen scavenging drugs, such as glycerol phenylbutyrate. These drugs can be safely administered to infants and toddlers by adjusting the dosage based on specific biomarkers, including urinary-PAGN and plasma PAA:PAGN ratio. Additionally, he has introduced methods for therapeutic monitoring of these nitrogen scavenging drugs. This includes evaluating daily ammonia exposure through a simple fasting ammonia blood measurement, which helps in adjusting dosage and determining the necessity of treatment for nitrogen retention disorders.

Career Highlights

Masoud Mokhtarani's career is highlighted by his tenure at notable companies such as Horizon Therapeutics, LLC and Hyperion Therapeutics, Inc. His work in these organizations has been pivotal in the development of therapeutic solutions that address complex medical conditions, showcasing his commitment to innovation in healthcare.

Collaborations

Throughout his career, Mokhtarani has collaborated with esteemed professionals in his field, including his coworker Bruce Scharschmidt. These collaborations underscore the importance of teamwork and shared expertise in driving advancements in medical technologies and treatments.

Conclusion

Masoud Mokhtarani's contributions to medicine, particularly in treating urea cycle disorders in neonates and infants, mark him as a visionary inventor. His extensive patent portfolio reflects his dedication to innovation, and his collaborations have amplified his impact on the healthcare industry. Through his work, he continues to pave the way for improved treatment methodologies and better outcomes for vulnerable patient populations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…